Skip to main content
TipRanks
Go Ultimate75% OFF
Kenai Therapeutics logo

Kenai Therapeutics: Valuation, Funding & Investors

San Diego, California, UShttps://www.kenaitx.com/Therapeutics

Kenai Therapeutics is a clinical-stage biotechnology company pioneering next-generation approaches to cure neurological conditions. The company develops off-the-shelf, allogeneic neuron replacement and gene-modified cell therapies, including RNDP-001 for idiopathic Parkinson's disease, and partners with FUJIFILM Cellular Dynamics for scalable, cryopreserved manufacturing.

Leadership & Board

Current Number of Employees
43
Current LinkedIn Followers
7,518

Latest Estimated Valuation

Total Amount Raised
$8M
Total Funding Rounds
1
Latest Funding Amount
$8M
Latest Funding Round
Investment

Employee Trend

Kenai Therapeutics had 43 employees as of November 16, 2026. The number of employees increased by 0 (0.00%) week-over-week.

43Latest Employee Count
0(0.00%)Week-Over-Week Change
020406080Jul 20, 2026Aug 03, 2026Aug 17, 2026Aug 31, 2026Sep 14, 2026Sep 28, 2026Oct 12, 2026Oct 26, 2026Nov 09, 2026

Social Trend

Kenai Therapeutics had 7,518 followers as of November 16, 2026. The number of followers increased by 21 (0.28%) week-over-week.

7,518Latest Followers Count
21(0.28%)Week-Over-Week Change
02,0004,0006,0008,000Jul 20, 2026Aug 03, 2026Aug 17, 2026Aug 31, 2026Sep 14, 2026Sep 28, 2026Oct 12, 2026Oct 26, 2026Nov 09, 2026

Funding Round

Funding DateFunding RoundAmount RaisedPost-Money Valuation
Jan 05, 2026Investment$8.00M―

Investors

Investor NameFunding Round
California Institute for Regenerative MedicineInvestment

Similar Companies

A snapshot of private companies similar to Kenai Therapeutics, helping you discover and navigate related company profiles.

Related News and Analysis